• Home
  • Contact Us
  • Try it!
  • Graphs
  • Publications
  • Blog

Follow us

Recent Posts

  • Biovista Vizit New Corpus: ClinicalTrials.gov September 16, 2025
  • Biovista Vizit New Corpus: MATISSE (a SoftMining algorithm) May 13, 2025
  • Biovista Vizit New Corpus: HPO March 4, 2025
  • Biovista Vizit January 2025 Release – AOP Features January 30, 2025
  • Uberon OBO Contribution May 22, 2024

Biovista Vizit

Biovista Vizit

  • Try it!
  • Graphs
  • Publications
  • Blog

Hepatitis and Autoimmune Diseases Drugs

August 24, 2018Autoimmune Diseases, Hepatitis, Vizit Graphs
Hepatitis and Autoimmune Diseases DrugsChristos Andronis2020-08-03T13:35:10-04:00
Hepatitis and Autoimmune Diseases Drugs

Managing infections and autoimmunity with Remicade and Ribavirin.

Explore the live graph.

Tags: CHRONIC HEPATITIS, CROHN DISEASE, HEPATITIS C, INFLAMMATORY BOWEL DISEASES, LIVER CIRRHOSIS, REMICADE, RHEUMATOID ARTHRITIS, RIBAVIRIN, ULCERATIVE COLITIS, VIRUS DISEASES

Post navigation

← TNF inhibitors and the microbiome
Biomarkers for Diabetes and Breast Cancer →
THROMBIN TARGET LESION IDENTIFICATION ULCERATIVE COLITIS TRACHEA TAU TROGLITAZONE THY-1 ANTIGENS TAUOPATHIES VASOCONSTRICTION VERO CELLS VASCULAR WOUND HEALING UBIQUITINATION VIRUS DISEASES TISSUE DEVELOPMENT TGF-BETA Uberon TYPE 2 DIABETES VEGFA THROMBOSIS TRANSLATION UCHL1 PROTEIN TP53 TUMOR THORAX TREPONEMA DENTICOLA TMPRSS2 VIRAL RELEASE FROM HOST CELL THROMBOCYTOPENIA TRASTUZUMAB VASODILATION TROPISM TIMELESS VGF PROTEIN VEGF VEINS TECFIDERA TUMOR PROGRESSION X-RAY COMPUTED TOMOGRAPHY TRANSPORT VITAMIN D TH17 CELLS TUMOR GROWTH

© 2026 Biovista Vizit All Rights Reserved.

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}